Mark Hollywood

Chief Tech/Sci/R&D Officer at ZYMEWORKS INC.

55 year

Health Technology

Commercial Services

Consumer Services

Profile

Mark Hollywood is currently the EVP & Head-Technical & Manufacturing Operations at Zymeworks BC, Inc. and the EVP, Head-Technical & Manufacturing Operations at Zymeworks, Inc. Previously, he worked as the Director-Quality Assurance & Quality Control at CellCyte Genetics Corp.
and as the Vice President & Head-ZymoGenetics at Bristol Myers Squibb Co. He obtained his undergraduate degree from Western Illinois University.

Mark Hollywood active positions

Companies	Position	Start
ZYMEWORKS INC.	Chief Tech/Sci/R&D Officer	2018-12-31
Zymeworks BC, Inc. Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.	Chief Tech/Sci/R&D Officer	2019-04-29

All active positions of Mark Hollywood

Former positions of Mark Hollywood

Companies	Position	End
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	2018-12-31
CELLCYTE GENETICS CORPORATION	Corporate Officer/Principal	-

See the detail of Mark Hollywood's experience

Training of Mark Hollywood

Western Illinois University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Hollywood's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
ZYMEWORKS INC.	Health Technology

Private companies	2
CellCyte Genetics Corp. CellCyte Genetics Corp. Miscellaneous Commercial ServicesCommercial Services CellCyte Genetics Corp. engaged in the discovery and development of stem cell therapeutic products. It enabled therapeutic advancements to safely deliver stem cells through the patient's own circulatory or vascular system directly into a specific diseased, damaged or dying organ. The company was founded on March 9, 2004 and was headquartered in Freeland, WA.	Commercial Services
Zymeworks BC, Inc. Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.	Health Technology

Private companies